Physician profile
Rachel Germano
NPI 1447927975
$880.75
in general payments reported to CMS, 2019-2025
21 companies · $19.10 in 2025
The $19.10 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55.50 · 2022: $467 · 2023: $287 · 2024: $51.79 · 2025: $19.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $124.99 | 2023 | |
| Pfizer INC. | $105.62 | 2022 | |
| Astellas Pharma US INC | $73.93 | 2021-2023 | Myrbetriq |
| 180 Medical, INC. | $71.02 | 2022 | |
| Merck Sharp & Dohme LLC | $63.11 | 2022-2023 | Keytruda, Lynparza, Welireg |
| Janssen Biotech, INC. | $62.22 | 2022-2023 | Erleada |
| Verity Pharmaceuticals INC. | $53.89 | 2023-2025 | Trelstar, Tlando |
| Sun Pharmaceutical Industries INC. | $44.87 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.49 | 2022 | |
| Hollister Incorporated | $35.68 | 2021 | |
| Procept Biorobotics Corporation | $25.21 | 2023 | Aquabeam Robotic System |
| Accord Healthcare, INC. | $23.49 | 2022 | |
| Sumitomo Pharma America, INC. | $20.30 | 2024 | Gemtesa |
| Urovant Sciences INC | $19.65 | 2022 | |
| Tolmar, INC. | $19.51 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $18.63 | 2022 | |
| Palette Life Sciences, INC. | $16.59 | 2022 | |
| Olympus America INC. | $16.43 | 2023 | Itind System |
| Tolmar Pharmaceuticals, INC. | $16.20 | 2022 | |
| Progenics Pharmaceuticals, INC. | $14.84 | 2024 | |
| Myriad Genetic Laboratories, INC. | $13.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Germano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.